Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ongoing first-line studies of epidermal growth factor receptor tyrosine kinase inhibitors in select patient populations.

Ongoing first-line studies of epidermal growth factor receptor tyrosine kinase inhibitors in select patient populations. Semin Oncol. 2005 Dec; 32(6 Suppl 10):S9-15.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.